Actively Recruiting
Effectiveness of Trauma Treatment in the Specialist Health Care Services
Led by Vestre Viken Hospital Trust · Updated on 2024-11-15
270
Participants Needed
1
Research Sites
322 weeks
Total Duration
On this page
Sponsors
V
Vestre Viken Hospital Trust
Lead Sponsor
N
Norwegian Center for Violence and Traumatic Stress Studies
Collaborating Sponsor
AI-Summary
What this Trial Is About
Post-traumatic stress disorder (PTSD) is a common mental illness. Treatments for PTSD are regarded as highly effective, but a large-scale, prospective, longitudinal randomized controlled trial comparing the effectiveness of these treatments has been requested by the research community. This study aims to conduct a comprehensive investigation into the effectiveness of two prominent PTSD therapies, eye movement desensitization and reprocessing (EMDR) and cognitive therapy for PTSD (CT-PTSD), within the Norwegian specialist health care services. The study aims to compare the therapy effectiveness, including their impact on comorbid disorders, complex PTSD symptoms, and functional outcomes post-treatment. Patients will be randomly assigned to EMDR or CT-PTSD and given manualized therapy aligned with their treatment goals. Each arm aims to recruit 135 patients, resulting in a total sample size of 270 patients. The main objective of this study is to examine the growth curves of the two methods and how patient characteristics affect their developments. Secondary short-term aims include (1) investigating the impact of EMDR and CT-PTSD on complex PTSD symptoms, (2) assessing effects on other clinical conditions and functional outcomes, and (3) exploring whether the therapeutic alliance mediates treatment effects. Secondary long-term aims are (1) to assess the long-term effects of EMDR and CT-PTSD on PTSD symptoms and (2) to explore the impact of extended or additional treatments on outcomes.
CONDITIONS
Official Title
Effectiveness of Trauma Treatment in the Specialist Health Care Services
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Diagnosed with PTSD based on the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) with a total score of 23 or higher
You will not qualify if you...
- Insufficient mastery of the Norwegian language
- Severe intellectual impairment with an estimated IQ of 70 or less
- Comorbid psychiatric illnesses in an acute phase requiring prioritized treatment such as hospitalization
- History of prior EMDR or cognitive therapy for PTSD treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Vestre Viken Health Trust
Drammen, Akershus, Norway, 3004
Actively Recruiting
Research Team
S
Susie Fu, PhD, Cand. Psychol.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here